Works by Elkamhawy, Ahmed
Results: 37
Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screening: Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors: A. Elkamhawy et al
- Published in:
- Archives of Pharmacal Research, 2025, v. 48, n. 2, p. 150, doi. 10.1007/s12272-025-01533-5
- By:
- Publication type:
- Article
Identification of 1H-purine-2,6-dione derivative as a potential SARS-CoV-2 main protease inhibitor: molecular docking, dynamic simulations, and energy calculations.
- Published in:
- PeerJ, 2022, p. 1, doi. 10.7717/peerj.14120
- By:
- Publication type:
- Article
Design and synthesis of new spirooxindole candidates and their selenium nanoparticles as potential dual Topo I/II inhibitors, DNA intercalators, and apoptotic inducers.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2242714
- By:
- Publication type:
- Article
Novel topoisomerase II/EGFR dual inhibitors: design, synthesis and docking studies of naphtho[2′,3′:4,5]thiazolo[3,2-a]pyrimidine hybrids as potential anticancer agents with apoptosis inducing activity.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2205043
- By:
- Publication type:
- Article
Development of new TAK-285 derivatives as potent EGFR/HER2 inhibitors possessing antiproliferative effects against 22RV1 and PC3 prostate carcinoma cell lines.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2202358
- By:
- Publication type:
- Article
Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2171029
- By:
- Publication type:
- Article
4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 994, doi. 10.1080/14756366.2022.2055553
- By:
- Publication type:
- Article
New horizons in drug discovery of lymphocyte-specific protein tyrosine kinase (Lck) inhibitors: a decade review (2011–2021) focussing on structure–activity relationship (SAR) and docking insights.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 1572, doi. 10.1080/14756366.2021.1937143
- By:
- Publication type:
- Article
Discovery of N-(1-(3-fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2020, v. 35, n. 1, p. 1568, doi. 10.1080/14756366.2020.1800666
- By:
- Publication type:
- Article
Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino)benzenesulfonamides as carbonic anhydrase isoforms I and II inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2019, v. 34, n. 1, p. 1457, doi. 10.1080/14756366.2019.1652282
- By:
- Publication type:
- Article
Discovery of a broad spectrum antiproliferative agent with selectivity for DDR1 kinase: cell line-based assay, kinase panel, molecular docking, and toxicity studies.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2016, v. 31, n. 1, p. 158, doi. 10.3109/14756366.2015.1004057
- By:
- Publication type:
- Article
Emerging Therapeutic Strategies for Parkinson's Disease and Future Prospects: A 2021 Update.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 371, doi. 10.3390/biomedicines10020371
- By:
- Publication type:
- Article
Development of New Meridianin/Leucettine-Derived Hybrid Small Molecules as Nanomolar Multi-Kinase Inhibitors with Antitumor Activity.
- Published in:
- Biomedicines, 2021, v. 9, n. 9, p. 1131, doi. 10.3390/biomedicines9091131
- By:
- Publication type:
- Article
Design and Synthesis of New [1,2,3]Triazolo[4,5- d]pyrimidine Derivatives as Potential Antiproliferative Agents.
- Published in:
- Bulletin of the Korean Chemical Society, 2015, v. 36, n. 7, p. 1863, doi. 10.1002/bkcs.10363
- By:
- Publication type:
- Article
Small Molecule c-KIT Inhibitors for the Treatment of Gastrointestinal Stromal Tumors: A Review on Synthesis, Design Strategies, and Structure–Activity Relationship (SAR).
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 11, p. 9450, doi. 10.3390/ijms24119450
- By:
- Publication type:
- Article
Suppression of Tumor Growth and Cell Migration by Indole-Based Benzenesulfonamides and Their Synergistic Effects in Combination with Doxorubicin.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 17, p. 9903, doi. 10.3390/ijms23179903
- By:
- Publication type:
- Article
Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 5, p. 2540, doi. 10.3390/ijms23052540
- By:
- Publication type:
- Article
The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6535, doi. 10.3390/ijms22126535
- By:
- Publication type:
- Article
Rational design, synthesis, biological evaluation, and molecular modeling of novel naphthamide derivatives possessing potent, reversible, and competitive inhibitory mode of action over human monoamine oxidase.
- Published in:
- Molecular Diversity, 2025, v. 29, n. 1, p. 179, doi. 10.1007/s11030-024-10841-9
- By:
- Publication type:
- Article
Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening.
- Published in:
- Molecules, 2021, v. 26, n. 17, p. 5324, doi. 10.3390/molecules26175324
- By:
- Publication type:
- Article
Structure Activity Relationship of Key Heterocyclic Anti-Angiogenic Leads of Promising Potential in the Fight against Cancer.
- Published in:
- Molecules, 2021, v. 26, n. 3, p. 553, doi. 10.3390/molecules26030553
- By:
- Publication type:
- Article
Synthesis and in Vitro Screening of Phenylbipyridinylpyrazole Derivatives as Potential Antiproliferative Agents.
- Published in:
- Molecules, 2015, v. 20, n. 1, p. 1031, doi. 10.3390/molecules20011031
- By:
- Publication type:
- Article
Highly Potent, Selective, and Competitive Indole-Based MAO-B Inhibitors Protect PC12 Cells against 6-Hydroxydopamine- and Rotenone-Induced Oxidative Stress.
- Published in:
- Antioxidants, 2021, v. 10, n. 10, p. 1641, doi. 10.3390/antiox10101641
- By:
- Publication type:
- Article
Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress.
- Published in:
- Antioxidants, 2021, v. 10, n. 10, p. 1604, doi. 10.3390/antiox10101604
- By:
- Publication type:
- Article
Novel saccharin analogs as promising antibacterial and anticancer agents: synthesis, DFT, POM analysis, molecular docking, molecular dynamic simulations, and cell-based assay.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.958379
- By:
- Publication type:
- Article
Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091954
- By:
- Publication type:
- Article
Small Molecules in Parkinson's Disease Therapy: From Dopamine Pathways to New Emerging Targets.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 12, p. 1688, doi. 10.3390/ph17121688
- By:
- Publication type:
- Article
Design, Synthesis, Biological Evaluation, and Molecular Dynamics Studies of Novel Lapatinib Derivatives.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 1, p. 43, doi. 10.3390/ph16010043
- By:
- Publication type:
- Article
Identification of Novel Aryl Carboxamide Derivatives as Death-Associated Protein Kinase 1 (DAPK1) Inhibitors with Anti-Proliferative Activities: Design, Synthesis, In Vitro, and In Silico Biological Studies.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 9, p. N.PAG, doi. 10.3390/ph15091050
- By:
- Publication type:
- Article
New N-Alkylated Heterocyclic Compounds as Prospective NDM1 Inhibitors: Investigation of In Vitro and In Silico Properties.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 7, p. N.PAG, doi. 10.3390/ph15070803
- By:
- Publication type:
- Article
Hit Identification of a Novel Quinazoline Sulfonamide as a Promising EphB3 Inhibitor: Design, Virtual Combinatorial Library, Synthesis, Biological Evaluation, and Docking Simulation Studies.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 12, p. 1247, doi. 10.3390/ph14121247
- By:
- Publication type:
- Article
Chalcone‐based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studies.
- Published in:
- Archiv der Pharmazie, 2024, v. 357, n. 11, p. 1, doi. 10.1002/ardp.202400069
- By:
- Publication type:
- Article
Design of new captopril mimics as promising ACE inhibitors: ADME, pharmacophore, molecular docking and dynamics simulation with MM-PBSA and PCA calculations.
- Published in:
- Journal of Taibah University for Science, 2023, v. 17, n. 1, p. 1, doi. 10.1080/16583655.2023.2210348
- By:
- Publication type:
- Article
Investigating the promising SARS-CoV-2 main protease inhibitory activity of secoiridoids isolated from Jasminum humile; in silico and in Vitro assessments with structure-activity relationship.
- Published in:
- Journal of Biomolecular Structure & Dynamics, 2024, v. 42, n. 13, p. 6941, doi. 10.1080/07391102.2023.2240419
- By:
- Publication type:
- Article
Novel Hybrid Indole-Based Caffeic Acid Amide Derivatives as Potent Free Radical Scavenging Agents: Rational Design, Synthesis, Spectroscopic Characterization, In Silico and In Vitro Investigations.
- Published in:
- Metabolites (2218-1989), 2023, v. 13, n. 2, p. 141, doi. 10.3390/metabo13020141
- By:
- Publication type:
- Article
Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life 2022, 12 , 876.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 6, p. 876, doi. 10.3390/life12060876
- By:
- Publication type:
- Article